KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $36.6 million.

  • Idexx Laboratories' Depreciation & Amortization (CF) rose 730.67% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.2 million, marking a year-over-year increase of 1127.36%. This contributed to the annual value of $129.9 million for FY2024, which is 1307.83% up from last year.
  • Per Idexx Laboratories' latest filing, its Depreciation & Amortization (CF) stood at $36.6 million for Q3 2025, which was up 730.67% from $35.8 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Depreciation & Amortization (CF) ranged from a high of $36.6 million in Q3 2025 and a low of $25.1 million during Q1 2021
  • For the 5-year period, Idexx Laboratories' Depreciation & Amortization (CF) averaged around $29.9 million, with its median value being $28.7 million (2022).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 94.94% in 2023, then skyrocketed by 1776.09% in 2024.
  • Quarter analysis of 5 years shows Idexx Laboratories' Depreciation & Amortization (CF) stood at $27.7 million in 2021, then grew by 3.7% to $28.7 million in 2022, then increased by 3.54% to $29.7 million in 2023, then rose by 13.35% to $33.7 million in 2024, then grew by 8.67% to $36.6 million in 2025.
  • Its Depreciation & Amortization (CF) was $36.6 million in Q3 2025, compared to $35.8 million in Q2 2025 and $34.1 million in Q1 2025.